These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 3126654)

  • 1. Management of gastrointestinal toxicity of nonsteroidal anti-inflammatory drugs during the therapy of rheumatic diseases. The rheumatologist's perspective.
    Robinson DR
    Am J Med; 1988 Feb; 84(2A):1-4. PubMed ID: 3126654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Recommendation for the prevention and treatment of non-steroidal anti-inflammatory drug-induced gastrointestinal ulcers and its complications].
    ;
    Zhonghua Nei Ke Za Zhi; 2017 Jan; 56(1):81-85. PubMed ID: 28056333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventing the gastrointestinal adverse effects of nonsteroidal anti-inflammatory drugs: from risk factor identification to risk factor intervention.
    Bardou M; Barkun AN
    Joint Bone Spine; 2010 Jan; 77(1):6-12. PubMed ID: 20022539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Gastrointestinal complications of non-steroid anti-inflammatory drugs (NSAID): problems to be solved. Rheumatologist's expert opinion].
    Nasonov EL; Karateev AE
    Eksp Klin Gastroenterol; 2006; (2):6-9. PubMed ID: 16866255
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal ulcers: role of mucosal protective and gastric antisecretory drugs.
    Dajani EZ; Agrawal NM
    Dig Dis; 1995 Jan; 13 Suppl 1():48-61. PubMed ID: 7697902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of pantoprazole compared with misoprostol for the prevention of NSAID-related gastrointestinal lesions and symptoms in rheumatic patients.
    Stupnicki T; Dietrich K; González-Carro P; Straszak A; Terjung A; Thomas KB; Lühmann R; Fischer R
    Digestion; 2003; 68(4):198-208. PubMed ID: 14707396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastroprotective therapy and risk of gastrointestinal ulcers: risk reduction by COX-2 therapy.
    Wolfe F; Anderson J; Burke TA; Arguelles LM; Pettitt D
    J Rheumatol; 2002 Mar; 29(3):467-73. PubMed ID: 11908558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of NSAID-induced gastrointestinal problems and the role of cimetidine in their prevention.
    Giercksky KE; Husby G; Rugstad HE; Revhaug A
    Aliment Pharmacol Ther; 1988; 2 Suppl 1():33-41. PubMed ID: 2979283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is no NSAID a good NSAID? Approaches to NSAID-associated upper gastrointestinal disease.
    Chang SY; Howden CW
    Curr Gastroenterol Rep; 2004 Dec; 6(6):447-53. PubMed ID: 15527674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of nonsteroidal anti-inflammatory drug-associated gastric and duodenal damage. Efficacy of antisecretory drugs and mucosal protective compounds.
    Pipkin G; Mills JG
    Dig Dis; 1995 Jan; 13 Suppl 1():75-88. PubMed ID: 7697904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention and treatment of ulcers induced by nonsteroidal anti-inflammatory drugs: an update.
    Dajani EZ; Agrawal NM
    J Physiol Pharmacol; 1995 Mar; 46(1):3-16. PubMed ID: 7599335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of nonsteroidal anti-inflammatory drug-induced gastropathy.
    Miller DR
    Clin Pharm; 1992 Aug; 11(8):690-704. PubMed ID: 1511542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nonsteroidal-anti-inflammatory drugs and serious undesirable gastrointestinal effects].
    Fabijanić D; Kardum D; Banić M; Fabijanić A
    Lijec Vjesn; 2007; 129(6-7):205-13. PubMed ID: 18018712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonsteroidal anti-inflammatory drugs: add an anti-ulcer drug for patients at high risk only. Always limit the dose and duration of treatment with NSAIDs.
    Prescrire Int; 2011 Sep; 20(119):216-9. PubMed ID: 21954519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of NSAID-induced gastrointestinal morbidity and mortality.
    Haslock I
    J Rheumatol Suppl; 1990 Feb; 20():2-6. PubMed ID: 2182852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction or relationship between Helicobacter pylori and non-steroidal anti-inflammatory drugs in upper gastrointestinal diseases.
    Ji KY; Hu FL
    World J Gastroenterol; 2006 Jun; 12(24):3789-92. PubMed ID: 16804960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs.
    McCarthy DM
    Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):755-73. PubMed ID: 11566039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastroduodenal complications of chronic NSAID therapy.
    Graham DY; Smith JL
    Am J Gastroenterol; 1988 Oct; 83(10):1081-4. PubMed ID: 3048080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of anti-ulcerative drugs in treatment and prevention of gastropathies induced by nonsteroidal anti-inflammatory drugs].
    Fialová P; Vlcek J
    Vnitr Lek; 2004 Nov; 50(11):858-66. PubMed ID: 15648967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylaxis and treatment of NSAID-induced gastroduodenal disorders.
    La Corte R; Caselli M; Castellino G; Bajocchi G; Trotta F
    Drug Saf; 1999 Jun; 20(6):527-43. PubMed ID: 10392669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.